8th Annual Tumour Models, San Francisco, CA, Jan 30-Feb 01, 2024
Conference
genOway presentation
Event
-
January 23, 2024
Jan 30-Feb 01, 2024
Implementing State-of-the-Art, Reproducible Preclinical Oncology Models to Accelerate Your Candidate’s Clinical Translatability

genOway’s presentation:
How to enhance translatability of immunotherapies in preclinical models
- Outlining BRGSF-HIS mice: Immunodeficient mice displaying functional human lymphoid and myeloid compartments, without GvHD and side effects
- Examining human cells functionality and assessing immune modulation induced by biologics in BRGSF-HIS model
- Showcase of assessment of immune targeting agents in immune checkpoint humanized models
Other news & events
Scientific excellence
From model design to experimental results
Tailor-made solutions adapted to scientific questionsRobust validation data on catalog models
Comprehensive dataset package
Generated with biopharma partners and in-houseCustomer care
Scientific follow-up and advice along the project
Collaborative approach for problem solving and development of innovative modelsEasy and fast access to models
Breeding facilities in US and Europe
Certified health status from professional breeders